Status:
COMPLETED
Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan
Lead Sponsor:
Pfizer
Conditions:
Pneumococcal Disease
Eligibility:
All Genders
28-60 years
Brief Summary
Streptococcus pneumoniae is a major cause of pneumonia, among infants and children in Japan and worldwideThis study plans to investigate the rate of invasive pneumococcal disease "IPD " and the rate o...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- \- Children residing in the surveillance area(s) aged 28 days to \<60 months with clinical suspicion of pneumonia, meningitis and bacteremia who were admitted to the hospital.
Exclusion
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
28511 Patients enrolled
Trial Details
Trial ID
NCT00757575
Start Date
February 1 2008
End Date
October 1 2010
Last Update
March 27 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kushiro, Hokkaido, Japan, 085-0032
2
Naha, Okinawa, Japan, 900-0034